Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis
2011

Insulin Use and Persistence in Type 2 Diabetes Patients

Sample size: 4752 publication Evidence: moderate

Author Information

Author(s): Bonafede Machaon M, Kalsekar Anupama, Pawaskar Manjiri, Ruiz Kimberly M, Torres Amelito M, Kelly Karen R, Curkendall Suellen M

Primary Institution: Thomson Reuters Inc

Hypothesis

What factors are associated with persistence to mealtime insulin among patients with type 2 diabetes on stable basal insulin therapy?

Conclusion

Mealtime insulin use and persistence were both considerably lower than expected, especially for human insulin compared to analogs.

Supporting Evidence

  • Patients primarily used vial/syringe (87%) and insulin analogs (60%).
  • Persistence to mealtime insulin was 40.7%, 30.2%, and 19.1% at 3, 6, and 12 months, respectively.
  • Initiating mealtime insulin with human insulin was a risk factor for non-persistence.
  • Older age, increased insulin copayment, mental health comorbidity, and polypharmacy were also predictors of non-persistence.

Takeaway

This study looked at how well patients with type 2 diabetes stick to their mealtime insulin after starting it, and found that many stop using it sooner than expected.

Methodology

A retrospective analysis using Thomson Reuters MarketScan® databases to assess insulin use and persistence among patients with type 2 diabetes.

Potential Biases

Potential for incomplete or miscoded claims impacting results.

Limitations

The study lacks data on lab values and physician behavior, which may affect the findings.

Participant Demographics

51% male, mean age 60.3 years.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1472-6823-11-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication